Upgrade to SI Premium - Free Trial

Plus Therapeutics (PSTV) Misses Q3 EPS by 37c

November 14, 2024 9:54 PM

Plus Therapeutics (NASDAQ: PSTV) reported Q3 EPS of ($0.37). Revenue for the quarter came in at $1.45 million.

For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.

Categories

Earnings